Cutaneous Infarction Under IL-12/23 p40 Inhibition: A Cautionary Note

被引：2

作者：

Lipsker, Dan ^{[1
]}

Lutz, Virginie ^{[1
]}

机构：

[1] Univ Strasbourg, Fac Med & Clin Dermatol, F-67091 Strasbourg, France

来源：

ARCHIVES OF DERMATOLOGY | 2011年 / 147卷 / 11期

关键词：

INTERLEUKIN-12/23; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; PSORIASIS; USTEKINUMAB; EFFICACY; SAFETY;

D O I：

10.1001/archdermatol.2011.318

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：1344 / 1345

页数：3

共 4 条

[1] A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis [J].

Krueger, Gerald G. ;

Langley, Richard G. ;

Leonardi, Craig ;

Yeilding, Newman ;

Guzzo, Cynthia ;

Wang, Yuhua ;

Dooley, Lisa T. ;

Lebwohl, Mark .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (06) :580-592

[2]

Leonardi CL, 2008, LANCET, V371, P1665, DOI 10.1016/S0140-6736(08)60725-4

[3] Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2) [J].

Papp, Kim A. ;

Langley, Richard G. ;

Lebwohl, Mark ;

Krueger, Gerald G. ;

Szapary, Philippe ;

Yeilding, Newman ;

Guzzo, Cynthia ;

Hsu, Ming-Chun ;

Wang, Yuhua ;

Li, Shu ;

Dooley, Lisa T. ;

Reich, Kristian .

LANCET, 2008, 371 (9625) :1675-1684

[4] Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis [J].

Taleb, Soraya ;

Romain, Melissa ;

Ramkhelawon, Bhama ;

Uyttenhove, Catherine ;

Pasterkamp, Gerard ;

Herbin, Olivier ;

Esposito, Bruno ;

Perez, Nicolas ;

Yasukawa, Hideo ;

Van Snick, Jacques ;

Yoshimura, Akihiko ;

Tedgui, Alain ;

Mallat, Ziad .

JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 206 (10) :2067-2077

← 1 →